Related Experiment Video

Updated: Jul 12, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas

T Nickl-Jockschat1, F Arslan, A Doerfelt

  • 1Department of Psychiatry and Psychotherapy, RWTH Aachen University, D-52074 Aachen, Germany.

International Journal of Oncology
|January 5, 2007
PubMed

Insights

Transforming growth factor-beta (TGF-beta) shifts roles in human gliomas. This study shows AS-11, an antisense oligodeoxynucleotide, impacts Smad and MAPK pathways, suggesting combined TGF-beta and MAPK pathway inhibition for glioma therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Signal Transduction

Background:

  • Transforming growth factor-beta (TGF-beta) has a dual role in human glioma pathobiology, acting as both a tumor suppressor and promoter.
  • TGF-beta signaling involves the Smad and MAPK pathways, which mediate distinct cellular effects crucial for glioma progression.
  • Understanding the interplay between these pathways is vital for developing effective glioma therapies.

Purpose of the Study:

  • To investigate the effects of TGF-beta2 and its antisense oligodeoxynucleotide (AS-11) on Smad and MAPK pathway functionality in high-grade gliomas.
  • To correlate pathway imbalances with differential behaviors of high-grade glioma cells.
  • To identify potential therapeutic strategies by targeting TGF-beta and MAPK signaling.

Main Methods:

  • Gene and protein expression analyses of Smad and MAPK pathway members under TGF-beta2 and AS-11 treatment.
  • Proliferation and migration assays to assess functional cellular responses.
  • Gene arrays to identify novel regulators involved in TGF-beta signaling and cellular behavior.

Main Results:

  • TGF-beta2 inhibited proliferation but enhanced migration in high-grade glioma cells.
  • AS-11 significantly reduced Smad 2 mRNA expression and activation, and downregulated K-ras.
  • ERK activity within the MAPK pathway was not affected by K-ras downregulation, suggesting RAS-independent activation cascades in glioma.

Conclusions:

  • TGF-beta signaling in high-grade gliomas involves K-ras, and the MAPK pathway (ERK) appears to be activated independently of RAS.
  • An imbalance between the Smad and MAPK pathways may contribute to TGF-beta's switch to a tumor-promoting role.
  • Combined antagonism of TGF-beta and MAPK pathways presents a promising therapeutic avenue for glioma treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...